TRANSLATION PHARMA LIMITED

Dissolved Chatham

Research and experimental development on biotechnology

4 employees website.com
Research and experimental development on biotechnology
T

TRANSLATION PHARMA LIMITED

Research and experimental development on biotechnology

Founded 18 Nov 2014 Dissolved Chatham, United Kingdom 4 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 3 May 2024
Confirmation Submitted 28 Nov 2023 Next due 2 Dec 2024 19 months overdue
Net assets £381K £47K 2023 year on year
Total assets £453K £24K 2023 year on year
Total Liabilities £72K £70K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Begbies Traynor, Innovation Centre Medway Maidstone Road Chatham Kent ME5 9FD

Full company profile for TRANSLATION PHARMA LIMITED (09316639), a dissolved company based in Chatham, United Kingdom. Incorporated 18 Nov 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2024
Type total-exemption-full
Next accounts
Due by

Net Assets, Total Assets & Total Liabilities (2015–2023)

Cash in Bank

£330.07k

Decreased by £93.97k (-22%)

Net Assets

£381.01k

Increased by £46.60k (+14%)

Total Liabilities

£71.63k

Decreased by £70.45k (-50%)

Turnover

N/A

Employees

4

Debt Ratio

16%

Decreased by 14 (-47%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jan Year End
2022
30 Nov Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Alasdair Mark NaylorDirectorBritishUnited Kingdom6518 Nov 2014Active
Alexander Robert LeechDirectorBritishUnited Kingdom5318 Nov 2014Active
Louise Helen NaylorDirectorBritishUnited Kingdom6610 Sept 2015Active

Shareholders

Shareholders (4)

Alasdair Naylor
25.0%
Alexander Robert Leech
25.0%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
19 Aug 2025InsolvencyLiquidation Voluntary Members Return Of Final Meeting
3 Jul 2024InsolvencyLiquidation Voluntary Appointment Of Liquidator
3 Jul 2024ResolutionResolutions
3 Jul 2024AddressChange Registered Office Address Company With Date Old Address New Address
3 Jul 2024InsolvencyLiquidation Voluntary Declaration Of Solvency
19 Aug 2025 Insolvency

Liquidation Voluntary Members Return Of Final Meeting

3 Jul 2024 Insolvency

Liquidation Voluntary Appointment Of Liquidator

3 Jul 2024 Resolution

Resolutions

3 Jul 2024 Address

Change Registered Office Address Company With Date Old Address New Address

3 Jul 2024 Insolvency

Liquidation Voluntary Declaration Of Solvency

Recent Activity

Latest Activity

Liquidation Voluntary Members Return Of Final Meeting

9 months ago on 19 Aug 2025

Liquidation Voluntary Appointment Of Liquidator

1 years ago on 3 Jul 2024

Resolutions

1 years ago on 3 Jul 2024

Change Registered Office Address Company With Date Old Address New Address

1 years ago on 3 Jul 2024

Liquidation Voluntary Declaration Of Solvency

1 years ago on 3 Jul 2024